Bp PLC Bristol Myers Squibb CO Transaction History

Bp PLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$59.17 - $69.31 $2.98 Million - $3.49 Million	-50,299 Closed	0 $0
Q2 2021 Aug 09, 2021	SELL	$61.91 - $67.42 $1.37 Million - $1.49 Million	-22,165 Reduced 30.59%	50,299 $3.36 Million
Q1 2021 May 13, 2021	SELL	$59.34 - $66.74 $10.4 Million - $11.7 Million	-175,200 Reduced 70.74%	72,464 $4.58 Million
Q4 2020 Feb 08, 2021	BUY	$57.74 - $65.43 $4.26 Million - $4.82 Million	73,725 Added 42.39%	247,664 $15.4 Million
Q3 2020 Oct 30, 2020	SELL	$57.43 - $63.64 $3.03 Million - $3.36 Million	-52,761 Reduced 23.27%	173,939 $10.5 Million
Q2 2020 Aug 05, 2020	SELL	$54.82 - $64.09 $4.02 Million - $4.7 Million	-73,300 Reduced 24.43%	226,700 $13.3 Million
Q1 2020 May 05, 2020	SELL	$46.4 - $67.43 $2.69 Million - $3.91 Million	-58,000 Reduced 16.2%	300,000 $16.7 Million
Q4 2019 Feb 07, 2020	BUY	$49.21 - $64.19 $9.5 Million - $12.4 Million	193,000 Added 116.97%	358,000 $23 Million
Q3 2019 Nov 13, 2019	BUY	$42.77 - $50.71 $85,540 - $101,420	2,000 Added 1.23%	165,000 $8.37 Million
Q2 2019 Jul 29, 2019	SELL	$44.62 - $49.34 $535,440 - $592,080	-12,000 Reduced 6.86%	163,000 $7.39 Million
Q4 2018 Feb 06, 2019	SELL	$48.76 - $63.23 $1.56 Million - $2.02 Million	-32,000 Reduced 15.46%	175,000 $9.09 Million
Q2 2018 Jul 30, 2018	BUY	$50.53 - $62.98 $808,480 - $1.01 Million	16,000 Added 8.38%	207,000 $11.5 Million
Q3 2017 Oct 30, 2017	BUY	$55.23 - $63.74 $10.5 Million - $12.2 Million	191,000	191,000 $12.2 Million

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Bp PLC, based on Form 13F filings with the SEC.

Stay updated on Bp PLC with notifications on news.